Skip to the page

Data / Form D filings / Klothea Bio, Inc.

Klothea Bio, Inc.: Form D filings

Klothea Bio, Inc., a health care company in Miami, FL, filed 4 Form D notices with the SEC between 2024 and 2026. The latest, on September 8, 2026, reports $6.9 million sold of a $10.4 million offering to 22 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
195 NW 40TH STREET, Miami, FL, 33127
Phone
(305) 846-9027
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2042705

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 8, 2026Amendment$10,385,000$6,885,000$3,500,00022Oct 11, 2024sec.gov
May 28, 2026Amendment$10,385,000$5,935,000$4,450,00018Oct 11, 2024sec.gov
Feb 2, 2026Amendment$11,130,000$2,935,000$8,195,00011Oct 11, 2024sec.gov
Oct 28, 2024New notice$11,130,000$1,000,000$10,130,0001Oct 11, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jeffrey B. MaddenExecutive Officer, Director
Agustin Fernandez Santana IIIExecutive Officer, Director
Olivier JarryExecutive Officer
Walter SchmidtDirector
Petr SramekDirector

Other health care companies in Florida that filed recently

Every Form D from the week of Sep 7, 2026 · All recent filings in Florida · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Klothea Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.